Posaconazole Tablet, Delayed Release
Product Images NDC 0904-7149

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 0904-7149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Posaconazole (B8e6d7a9 Ab88 4845 B08d 513ebd10a0ea 01)

Posaconazole (B8e6d7a9 Ab88 4845 B08d 513ebd10a0ea 01)
Chemical structure diagram of the active ingredient posaconazole, showing its molecular arrangement including multiple aromatic rings, fluorine atoms, and functional groups such as hydroxyl and triazole rings.*
FDA Label Image

100mg Carton Label (Ef76e94c F183 4eef 8fee A52635cdcd34 00)

100mg Carton Label (Ef76e94c F183 4eef 8fee A52635cdcd34 00)
POSACONAZOLE delayed-release tablets 100 mg oral unit dose packaging label by Major Pharmaceuticals. The label shows the product name, strength, dosage form, and quantity of 30 tablets (3x10). It includes storage instructions, a notice about dosing differences, trademark info, and packaging details. The label also has a barcode and distributor information from Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.